Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Cebu Landmasters raising P5 billion from notes issue

2018-07-20 bworldonline
CEBU Landmasters, Inc. (CLI) signed on Friday a P5-billion corporate notes facility agreement, with the proceeds to be used to acquire land in various cities and develop a business hub in Davao City.
BDOUF BDO CHIB BDOUY CKGOY

0
Cebu Landmasters inks P5-billion notes facility

2018-07-20 bworldonline
Cebu Landmasters, Inc. (CLI) has signed on Friday, July 20, a P5-billion corporate notes facility agreement, with the proceeds to be used to acquire land and develop a business hub in Davao City.
BDOUF BDO CHIB BDOUY CKGOY

0
Investors turn attention to earnings reports

2018-07-17 bworldonline
THE MAIN INDEX eked out last-minute gains on Tuesday after moving within a tight range as investors await the release of corporate earnings results in the coming weeks.
PSKXF BDOUY AYAAY UVRBY SECB BDOUF BDO MWP SYBJF URC PHSXY PSE MWIDE ALI UVRBF AYAAF

0
Bourse caps four-day rally amid lack of leads

2018-07-16 bworldonline
The bellwether Philippine Stock Exchange index (PSEI) snapped its four-day winning streak Monday, July 16, dropping 29.74 points or 0.4% to end at 7,369.44, while the broader all-shares index gave up 12.29 points or 0.27% to finish at 4,462.60.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

0
PSEi ends four-day rally

2018-07-16 bworldonline
Local equities slumped on Monday, July 16, as the market continued to consolidate within range due to lack of catalysts.
SVTMF PSKXF BDOUY AYAAY SM BDOUF BDO SMIVY MWP PHSXY PSE MWIDE ALI AYAAF

3
Asia’s newest millionaires swap basket-case economy for fine art

2018-07-12 bworldonline
IN THE PHILIPPINES, where a fifth of the country lives beneath the poverty line, locals have a new obsession: fine art.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

3
Asia's Newest Millionaires Swap Basket-Case Economy for Fine Art - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBARF DSLV VIIX DGLD CSSLF VIIZ BDOUY AYAAY CS JBAXY BDOUF BDO CSGKF UGLD ZIV USLV TVIX ALI AYAAF XIV

0
PSEi closes up 0.65%

2018-07-10 business.inquirer.net
The benchmark Philippine Stock Exchange Index (PSEi) closed above the 7,200 level yesterday, lifted by bargain hunters.
ICT SVTMF BDOUY AYAAY JBFCY SM AEV ICTEF BDOUF BDO SMIVY JBFCF ABTZY JFC ALI AYAAF

0
PSEi rallies to 7,300 level, but market still seen technically weak

2018-07-04 business.inquirer.net
The local stock barometer rallied to the 7,300 level yesterday on the back of some foreign inflows amid expectations that the market may have found the bottom.
BDOUF BDO SMIVY PSKXF SVTMF BDOUY SYBJF PHSXY SM PSE SECB

24
Index slides 1.53%

2018-06-28 business.inquirer.net
The benchmark Philippine Stock Exchange index (PSEi) slid anew yesterday amid mixed sentiments in the region and the decline in Wall Street overnight.
PSKXF BDOUY AYAAY JBFCY AEV BDOUF SMPH BDO JBFCF ABTZY SPHXY JFC PHSXY PSE SPHXF SPHZF ALI AYAAF

10
Philippines ETF in Focus as Central Bank Raises Rates

2018-06-26 zacks
The emerging markets continue to struggle on account of Fed rate hikes and continued sell-off by foreign investors. As the Asian markets remain volatile, the Philippines’ stocks declined 2% on Jun 21, largely due to a stronger dollar performance and persistent selling in the equity markets.
BDOUF BDO BDOUY AYAAY ALI AYAAF

5
The Philippines growth dialogues: Unlocking digital banking opportunities

2018-06-26 bworldonline
The Philippines growth dialogues, a collaboration between McKinsey and BusinessWorld, is a video series presenting the ideas of influential leaders in the public, private, and social sectors about key opportunities to promote economic growth in the Philippines. This third installment focuses on the banking sector.
BDOUF BDO BDOUY

36
Bargain hunters splurge as PSEi breaks 7,000 mark

2018-06-22 business.inquirer.net
The benchmark Philippine Stock Exchange index (PSEi) continued its descent on Friday, briefly dropping below the 7,000 level before bargain hunters entered the fray.
MER SVTMF PSKXF MPCIY BDOUY AYAAY JBFCY SM BDOUF SMPH BDO SMIVY JBFCF MPI MPCFF SPHXY JFC PHSXY PSE SPHXF SPHZF ALI AYAAF

74
What’s wrong with Asian stocks? Theories from Goldman and others

2018-06-22 malaymail
HONG KONG, June 22 — It’s been a tumultuous two weeks for equity traders in Asia. And at some point, it just gets to be too much — strategists from Goldman Sachs Group Inc to Morgan Stanley have begun slashing their forecasts.
BDOUY GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA BDOUF GS GLSSP UBS UBS.PRDCL MS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BDO MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN ULSGF GS.PRK

74
What's wrong with Asian stocks? Theories from Goldman and others

2018-06-21 theedgemarkets
HONG KONG (June 22): It’s been a tumultuous two weeks for equity traders in Asia. And at some point, it just gets to be too much — strategists from Goldman Sachs Group Inc to Morgan Stanley have begun slashing their forecasts.
BDOUY GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA BDOUF GS GLSSP UBS UBS.PRDCL MS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BDO MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN ULSGF GS.PRK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...